A few rambling thoughts:
1) Thank you for
the information re: the ABT alliance. I hope that
there will be analyst confirmations during the next 2
weeks. I agree with McMonalpha that the company should
provide a straightforward summary of the deals - on their
site is fine. Well, I'll mention it again at the next
stockholders meeting (in May).
2) I remain confident
that supg negotiated from strength ... and cut an
My warrants are starting to look real
good - I like paying $9/share.
3) I am
intrigued with the focus on delivery systems. The company
has already got the extra technology. That, coupled
with the inhaled technology - and a novel way to
sustain emulsions for longer periods of time all might
well add up to a very effective new line as well as
providing a key differentiation point for
generics/off-patent products. Hmm. I'll need to look into this in
more detail - Boogins got any thoughts about
4) Happy new century to all on the
board (except for the twerp who posts doom and gloom
with no back-up data ... the "rape of supg by abt"
come on - get real).
dshlm (from the outback
... I am using my sister-in-law's old Mac ... it is
Post # 8941 by
>>>>>>> While I was complaining about things to a member
of the IR staff at SUPG she told me I would soon be
seeing more details from investment analysts.
Post #8950 by
>>>> The details will be out soon enough and this
board will be pleased. <<<<
possible could you please define "soon" in days, weeks or
months or what you feel may be likely and
yes, Taxol reacts with the PVC and plastics... so
they do use alternative materials which are sold in
packs along with the TAXOL supply. I don't remember if
these "packs" are from somewhere else, but I think so.
Regarding your point B I hope you are right in
your presumption. I've read and re-read that portion
of the bloomberg release numerous times. I still
don't know what it means. Is it purposely nebulous? .
"The agreement calls for Abbott to make up to $150
worth of additional one-time payments,
including equity purchases that would
give Abbott as
much as 19 percent of SuperGen, Rubinfeld said."
(pasted from the e-mail the SUPG IR department sent
In my opinion, if the $150 million is cash milestone
payments than this is a good deal. If the $150 million is
for 15% of SUPG then the cost to ABT is about $37.50
A press release should be
understandable and not just released to bloomberg, and then
whispered to analysts. If the initial purchase was at $35 a
share SUPG got a $3 million premium over the price of
SUPG at the time of the news release for the stock
they sold ABT.
PS - Being told by the IR
contact that the company would be giving more details to
the analysts is unsettling to me. I resent selective
disclosure on any company I follow. I hope you are right
about the $150 million being cash milestone payments.
Oh well, I guess I'll just have to wait for an
analysts report to come out.
These details that litlebucks is bringing to
light are the first I've heard of as far as the option
expiration date and price are concerned. 42 months from now
$85 dollars will be a huge bargain to ABT for SUPG
stock, I believe. Also, the additional payments for R&D
and royalties is news to me. If all this is true,
then Dr. Joe has indeed cut a deal highly beneficial
to SUPG, particularly if no equity changes hands for
the $150 million in milestone payments. ABT also did
well with the options since they are not at risk and
can only win if SUPG is successful. 50/50......I love
that part of the deal. This deal was built to give
both companies incentive to help the other succeed. In
case you can't tell, I'm liking what I
RE: Taxol, EAD does taxol react with
polyvinylchloride and thus the restriction of use with PVC? If so,
are there other plastic or perhaps non-plastic
delivery methods to ventilate that aren't reactive?
Litlebucks....thank you for your informative post.
Thanks for the post. It
was well-written and gave me some new avenues to
explore in my research on SUPG. I am still holding all of
my shares. However, I saw two recent messages on
Silicon Investor's SUPG board where the posters sold all
but 100-200 shares of their SUPG holdings.
wrote: "The consensus is that the press release on
wednesday was written by ABT and the information SUPG
wanted included was left off for some reason by ABT. I
have heard that Dr joe was very unhappy about that and
discussed it with ABT. ABT's answer was put the details in
your 10 k."
The SUPG SEC filings could prove to
have some valuable information. Maybe, SUPG will even
put more of the details on their
Happy holidays and a Prosperous Portfolio to you and
all of the lurkers and posters on this board. MLD38
Working for a major-pharma, I suspected as much
about the announcement as you so kindly informed us
Remember peoples, ABT could care less about SUPG's
investors (only their own). HOWEVER, ABT does has vested
interest in SuperGen's success.
I do believe that
Dr. Joe has just spoken. Thank you, Dr. Joe for
Pacer... the missing pieces that
littlebucks filled in are all true... Dr. Lenaz has never had
a drug turned down by the FDA. In fact, his name is
connected to the most successful anti-cancer agents in
oncology history. Another true fact -- every early
compound he was proud to stand behind was a blockbuster.
Every compound he had doubts about and would not stand
behind, were usually done and forgotten in Phase I. The
man has a nose for what works. That's not hype...
it's fact. I understand that Raj was just as
successful on the Regulatory side (correct me if I'm wrong,
but I don't believe I am.)
No... BMY never had a "patent" on TAXOL, just
"exclusivity rights." Its semi-synthetic formulation is
patented and its delivery system, as our new envoy here
has just pointed out, but not paclitaxel itself. So,
it is quite feasible that paclitaxel with an
alternative delivery system could be sold by SuperGen. Taxol
cannot be infused with any standard PVC tubing.